PUTTINI MIRIAM

GAMBACORTI PASSERINI, C., Antolini, L., Piazza, R., Guilhot, F., Deininger, M., Fava, C., et al. (2011). Imatinib Long-Term Effects Study: Global Independent Assessment of Imatinib in Chronic Myeloid Leukemia: Results At 8 Years. In ASH 2011; 53rd Congress of the American Society of Hematology (pp.1608-1608). AMER SOC HEMATOLOGY. Dettaglio

GAMBACORTI PASSERINI, C., Antolini, L., Mahon, F., Guilhot, F., Deininger, M., Fava, C., et al. (2011). Multicenter Independent Assessment of Outcomes in Chronic Myeloid Leukemia Patients Treated With Imatinib. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 103(7), 553-561 [10.1093/jnci/djr060]. Dettaglio

Tornaghi, L., Meneghetti, I., Dilda, I., Puttini, M., Piazza, R., Antolini, L., et al. (2009). Imatinib long term effects study: three years of follow-up and assessment. In SIE 2009; 42nd Congress of the Italian Society of Hematology. Il Pensiero Scientifico. Dettaglio

Puttini, M., Redaelli, S., Moretti, L., Brussolo, S., Gunby, R., Mologni, L., et al. (2008). Characterization of compound 584, an Abl kinase inhibitor with lasting effects. HAEMATOLOGICA, 93(5), 653-661 [10.3324/haematol.12212]. Dettaglio

Galietta, A., Gunby, R., Redaelli, S., Stano, P., Carniti, C., Bachi, A., et al. (2007). NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma. BLOOD, 110(7), 2600-2609 [10.1182/blood-2006-01-028647]. Dettaglio